Komori
Alfresa Holdings (2784) · FactFirst stated

Revenue and profit growth in the FY2023 self-medication wholesale business

First written in FY2023. . Latest entry: FY2023.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Higher Revenue and Profit in the Self-Medication Wholesale Business Driven by a Recovery in Inbound DemandA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2023First statedAnnual report

    「当セグメントの当連結会計年度の業績は、売上高2,466億79百万円(前期比0.8％増)、営業利益21億10百万円(同12.9％増)となりました。」

    セルフメディケーション卸売事業は、インバウンド需要の回復と利益・コスト管理等により増収増益となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.